0.00Open0.00Pre Close0 Volume0 Open Interest49.50Strike Price0.00Turnover316.44%IV-36.33%PremiumMay 9, 2025Expiry Date13.19Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8331Delta0.0236Gamma2.77Leverage Ratio-0.3892Theta-0.0035Rho-2.31Eff Leverage0.0084Vega
TG Therapeutics Stock Discussion
TG Therapeutics Crushes Earnings: MS Drug BRIUMVI Drives 137% Growth, Company Turns Profitable
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet